Evidence map›Paper›PMID 40722688›Full record

ArticleBiomedicines2025

Long COVID and Its Impacts: A Case-Control Study in Brazil.

Cristina M Ruas, Maria Laura Silva, Ana L G F Figueiredo, Amanda P de Alencar, Samuel de S Melo, Geovani F de Castro, Natália V Carobin, Melina A Cordeiro, Janete F R Aguirre, Amanda F M de Oliveira and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cristina M RuasSocial Pharmacy Department, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Maria Laura SilvaSchool of Pharmacy, University of Bordeaux, 33000 Bordeaux, France.ORCID 0000-0003-2215-4118
Ana L G F FigueiredoClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Amanda P de AlencarClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0009-0004-7301-8233
Samuel de S MeloClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Geovani F de CastroSocial Pharmacy Department, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Natália V CarobinClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0000-0002-3830-2640
Melina A CordeiroClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Janete F R AguirreSocial Pharmacy Department, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID 0009-0003-2306-9369
Amanda F M de OliveiraSocial Pharmacy Department, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Adriano de P SabinoClinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.

Funding

MCTI/FINEP 27968*17 - FINEP/RTR/PRPq/REDE COVID-19 - UFMG - LINBIO
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

case–control studiesCOVID-19post-acute COVID-19 syndrome

Identifiers

PMID40722688
PMCPMC12292682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.